Photo: Capsugel's Licaps product.

Lonza, one of the world’s leading suppliers to the pharmaceutical, biotech, and specialty ingredients markets, announced plans to expand operations in Greenwood County. The company is investing $46 million over the next five years and is expected to generate 30 new jobs.

Headquartered in Basel, Switzerland, Lonza harnesses science and technology to create products that enhance the overall quality of life for patients and consumers around the world. Through its acquisition of Capsugel in July 2017, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms.

Lonza’s Greenwood County operations, which are located at 535 North Emerald Road, produce empty capsules and finished dosage forms for the global biopharma and consumer health and nutrition markets. To expand, the company is adding approximately 50,000 square feet of new manufacturing space, which will enable the firm to produce key nutritional ingredients, among other projects.

Construction is expected to be completed in the second quarter of 2019.

The Coordinating Council for Economic Development has approved a $300,000 Set Aside grant to Greenwood County to assist with the costs of site work and infrastructure improvements.  

“Lonza is making a significant investment in our operations in Greenwood, further demonstrating our commitment to providing high-quality products and services to our customers worldwide," said Specialty Ingredients COO Sven Abend. "Greenwood County is rich with talented, skilled individuals who will enhance our global and regional footprint, particularly in the area of consumer health and nutrition.”